reports
- ABGSC IT Research
- Mikkel Kousgaard Rasmussen
Verkkokauppa.com Oyj: 1 director
A director at Verkkokauppa.com Oyj sold 280,000 shares at 2.200EUR and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D), today announced that Jay Skyler, MD, MACP, FRCP has been appointed to the company’s Board of Directors. “Dr. Skyler’s appointment to our Board of Directors is a major milestone for SAB,” said Samuel J. Reich, SAB’s chairman...
Flow Capital Announces Repayment of USD 4.5 Million Investment
Flow Capital Announces Repayment of USD 4.5 Million Investment TORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV: FW) ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on providing flexible growth financing solutions to small and mid-cap high-growth companies across multiple sectors. With the help of our capital, companies are better able to execute their growth plans, scale their operations more aggres...
N2OFF: Save Foods to Target California’s Hemp Market
N2OFF: Save Foods to Target California’s Hemp Market More than half of US hemp flower grown in California recently received Pre-Harvest Regulatory Approval in California allowing Save Foods to treat hemp Neve Yarak, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- \ (NASDAQ: NITO) (FSE:80W) (“N2OFF” or the “Company”), a pioneer agri-food tech company offering sustainable solutions for agriculture and plant-based food, announced today that its subsidiary Save Foods Ltd. (“Save Foods”) is set to target the hemp flower market in California. The Company recently announced that the California Depar...
Skyward Specialty Announces Secondary Offering of Its Common Stock
Skyward Specialty Announces Secondary Offering of Its Common Stock HOUSTON, May 06, 2024 (GLOBE NEWSWIRE) -- Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) (“Skyward Specialty” or the “Company”) a leader in the specialty property and casualty (“P&C”) market, announced that The Westaim Corporation (“Westaim”), through its wholly-owned subsidiary, Westaim HIIG GP Inc. (the “Selling Stockholder”) is offering 4,400,000 shares of the Company’s common stock in an underwritten secondary public offering. In connection with the offering, the Selling Stockholder has also granted the underwr...
- Research Department
ESTRATEGIA SEMANAL DE CRÉDITO: EL EMPLEO AMERICANO PONE TECHO AL TREAS...
Entorno: Los últimos datos de empleo americanos acercan la posibilidad de ver dos bajadas de tipos en EE.UU. este año, propiciando estrechamientos en la curva de deuda y devolviendo el apetito por el riesgo en los índices de crédito de beta alta. Para esta semana tendremos reunión del BoE (9 mayo). En EE.UU. pocas referencias durante la semana, apenas peticiones de empleo y confianza del consumidor preliminar de mayo. En la Eurozona conoceremos los PMI’s finales de abril, mientras que en Alemani...
Clariane : Modalités de mise à disposition et de consultation des info...
PARIS--(BUSINESS WIRE)-- Regulatory News: Clariane (CLARIA.PA – ISIN FR0010386334) (Paris:CLARI) informe ses actionnaires qu’une Assemblée générale mixte (l’« Assemblée générale ») de la Société se tiendra le lundi 10 juin 2024 à 10 heures à la salle Apostrophe, située 83 avenue Marceau, 750016 Paris. L’avis préalable de réunion comportant l’ordre du jour, le texte des projets de résolutions présentés par le Conseil d’administration ainsi que les modalités de participation et de vote à l’Assemblée générale a été publié au Bulletin des Annonces Légales Obligatoires n° 55 du 6 mai 2024. Le...
ALLETE Enters Agreement to be Acquired by a Partnership Led by Canada ...
DULUTH, Minn.--(BUSINESS WIRE)-- ALLETE, Inc. (NYSE: ALE) and a partnership led by Canada Pension Plan Investment Board (“CPP Investments”) and Global Infrastructure Partners (“GIP”), (the “partnership”), today jointly announced that they have entered into a definitive agreement under which the partnership will acquire ALLETE for $67.00 per share in cash, or $6.2 billion including the assumption of debt. ALLETE is a leading energy company and provider of safe, reliable, and competitively priced energy with a national footprint. Together, ALLETE and its family of companies, which includes reg...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region ...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in Algeria with the FIAT Professional brand Confirms market leadership in Europe 30 and South AmericaNorth America plays a key role in Pro One success; Ram announces new professional commercial vehicle divi...
AMG Reports Financial and Operating Results for the First Quarter of 2...
AMG Reports Financial and Operating Results for the First Quarter of 2024 Company reports EPS of $4.14, Economic EPS of $5.37 in first quarter Net Income (controlling interest) of $150 million, Economic Net Income (controlling interest) of $187 millionEconomic Earnings per share increased 28% year-over-year, reflecting strong business momentum and the positive impact of our capital allocation strategyIssued $450 million of 40-year junior hybrid debt and repurchased approximately $150 million in common stock WEST PALM BEACH, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AMG, a leading partner t...
Sanergy Group Limited: 1 director
A director at Sanergy Group Limited sold 78,000,000 shares at 2.580HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Anton Oilfield Services Group: 1 director
A director at Anton Oilfield Services Group sold 1,125,000 shares at 0.426HKD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Hi...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data demonstrating potential of a MYC-targeting epigenomic controller in NSCLC at AACR 2024Company to present new preclinical data demonstrating durable epigenomic upregulation and other OMEGA platform capabilities at ASGCT 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- O...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and ...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report first quarter 2024 financial and operating results after market close on Monday, May 13, 2024. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET to review its financial and operating results. To participate via telephone and join the call live, please register in advance here: . Upon reg...
KP Tissue Announces Filing and Mailing of the Management Proxy Materia...
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2024 Annual Meeting of Shareholders Your vote is important no matter how many shares you own. Vote today.Shareholders who have questions or need assistance with voting should contact KP Tissue’s proxy solicitation agent and shareholder communications advisor, Laurel Hill Advisory Group, by telephone at 1-877-452-7184 or by email at . MISSISSAUGA, Ontario, May 06, 2024 (GLOBE NEWSWIRE) -- KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) is pleased to announce its notice of annual meeting of sh...
Inari Medical to Participate in the 2024 Bank of America Securities He...
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time. A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relations” sectio...
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerati...
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerating Growth in 2024 Net profit margin increased to 6.4% in 2023, up from 6.1% in 2022 Capital from IPO driving new customer acquisitions and production capacity expansion International expansion and innovative product launches position LOBO for growth in 2024 WUXI, China, May 06, 2024 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric vehicle manufacturer and seller, today announced its financial results for the fiscal year ended December 31, 2023....
Papiers Tissu KP annonce le dépôt et l'envoi des documents de procurat...
Papiers Tissu KP annonce le dépôt et l'envoi des documents de procuration de la direction dans le cadre de l’assemblée annuelle des actionnaires de 2024 Votre vote est important, quel que soit le nombre d'actions que vous détenez. Votez dès aujourd'hui!Les actionnaires ayant des questions ou ayant besoin d'aide pour voter sont invités à contacter l'agent de sollicitation de procurations et le conseiller en communication auprès des actionnaires de Papiers Tissu KP, le Laurel Hill Advisory Group, par téléphone au 1 877 452-7184 ou par courriel à . MISSISSAUGA, Ontario, 06 mai 2024 (GLOBE N...
Can-Fite Received Notice of Allowance from the European Patent Office ...
PETACH TIKVA, Israel--(BUSINESS WIRE)-- . (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the European Patent Office for its patent application titled “An A3 Adenosine Receptor Ligands For Use in Treatment of a Sexual Dysfunction”. This invention addresses the use of the CF602 drug candidate as an oral or topical drug for patients such as diabetics, who suffer from erectile dysfunction, and cannot use the current drugs on...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.